Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY. | BIORELIANCE CORPORATION | $248,779 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 621511Medical Laboratories | Q301MEDICAL- LABORATORY TESTING | Sep 26, 2024 | Sep 26, 2024 | Sep 24, 2026 | ||
| BIORELIANCE EXPI293F | BIORELIANCE CORPORATION | $672,262 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jul 16, 2021 | Jul 16, 2021 | Jul 15, 2026 |